Carrie Bourdow
-
Chesterbrook-based Trevena Reduces Workforce, Continues to Evaluate Future Options
Chesterbrook-based Trevena, which was delisted from NASDAQ last month, has brought its workforce down to four full-time employees and is currently evaluating the options for…
-
Chesterbrook-Based Trevena Receives Milestone Payment from Licensing Partner in China
After the FDA approved its new pain medication, Olinvyk, earlier this month, Chesterbrook-based Trevena has received a $3 million milestone payment from its licensing partner…
-
Pair of Chester County Companies Working on Potential COVID-19 Treatments
Chesterbrook-based Trevena and Wayne-based Aclaris Therapeutics have joined the growing list of drug developers currently working on potential COVID-19 treatments, writes John George for the…
-
If at First You Don’t Succeed … Chesterbrook-Based Trevena Tries Again with Experimental Opioid
Chesterbrook-based Trevena has refiled its drug application to the Food and Drug Administration for IV oliceridine, an opioid pain relief medicine with fewer side effects…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
